![](/img/cover-not-exists.png)
PSA time to nadir as a prognostic factor of first-line docetaxel treatment in castration-resistant prostate cancer: Multicenter validation in patients from the Chinese Prostate Cancer Consortium
Pei, Xinqi, Wu, Kaijie, Sun, Yinghao, Gao, Xu, Gou, Xin, Xu, Jun, Gao, Fan, He, Dalin, Li, LeiLanguage:
english
Journal:
Urologic Oncology: Seminars and Original Investigations
DOI:
10.1016/j.urolonc.2019.07.014
Date:
October, 2019
File:
PDF, 820 KB
english, 2019